The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer

The effects of enzalutamide monotherapy on prostate tumor downsizing and multiparametric MRI are currently unknown. Here we present the first case in literature of a patient with high-grade prostate cancer who underwent 3 months of neoadjuvant enzalutamide, for which the effects on mpMRI and histolo...

Description complète

Détails bibliographiques

Auteurs principaux:	Rosanne CV. Van der Roest, Petra J. van Houdt, Stijn WTPJ. Heijmink, Jeroen de Jong, André M. Bergman, Wilbert Zwart, Uulke A. van der Heide, Henk G. van der Poel
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2016-07-01
Collection:	Urology Case Reports
Sujets:	Antiandrogen Enzalutamide Histology MRI Prostate cancer
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2214442016300389
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!